- Home
- NDRA vs KTTA Comparison
NDRA vs KTTA Comparison
Compare NDRA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- KTTA
- Stock Information
- Founded
- NDRA 2007
- KTTA 2020
- Country
- NDRA United States
- KTTA United States
- Employees
- NDRA N/A
- KTTA N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- KTTA Health Care
- Exchange
- NDRA Nasdaq
- KTTA Nasdaq
- Market Cap
- NDRA 3.6M
- KTTA 3.2M
- IPO Year
- NDRA 2017
- KTTA 2021
- Fundamental
- Price
- NDRA $6.01
- KTTA $2.48
- Analyst Decision
- NDRA Strong Buy
- KTTA
- Analyst Count
- NDRA 1
- KTTA 0
- Target Price
- NDRA $14,000.00
- KTTA N/A
- AVG Volume (30 Days)
- NDRA 36.2K
- KTTA 43.9K
- Earning Date
- NDRA 11-15-2024
- KTTA 11-13-2024
- Dividend Yield
- NDRA N/A
- KTTA N/A
- EPS Growth
- NDRA N/A
- KTTA N/A
- EPS
- NDRA N/A
- KTTA N/A
- Revenue
- NDRA N/A
- KTTA N/A
- Revenue This Year
- NDRA N/A
- KTTA N/A
- Revenue Next Year
- NDRA N/A
- KTTA N/A
- P/E Ratio
- NDRA N/A
- KTTA N/A
- Revenue Growth
- NDRA N/A
- KTTA N/A
- 52 Week Low
- NDRA $4.01
- KTTA $2.20
- 52 Week High
- NDRA $2,240.00
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- NDRA 51.58
- KTTA 38.84
- Support Level
- NDRA $5.60
- KTTA $2.20
- Resistance Level
- NDRA $6.29
- KTTA $2.61
- Average True Range (ATR)
- NDRA 0.60
- KTTA 0.28
- MACD
- NDRA 0.02
- KTTA -0.03
- Stochastic Oscillator
- NDRA 27.29
- KTTA 24.35
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.